← Back
$CNTA All transactions

Centessa Pharmaceuticals plc

M 10b5-1 Plan

$ Value

$35K

Shares

6,000

Price

$6

Filed

Aug 15

Insider

Name

HUSSAIN IQBAL J

Title

General Counsel

CIK

0001862050

Roles

Officer

Transaction Details

Transaction Date

2025-08-15

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

111,386

Footnotes

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 14, 2024. | 25% of the shares subject to such option shall vest and become exercisable on February 19, 2022 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter.

Filing Info

Accession No.

0001847903-25-000137

Form Type

4

Issuer CIK

0001847903

HUSSAIN IQBAL J's History

Date Ticker Type Value
2026-02-02 CNTA $980K
2026-02-02 CNTA A $0
2026-02-02 CNTA A $0
2026-02-02 CNTA A $0
2026-02-01 CNTA F $191K
2026-01-30 CNTA $25K
2025-11-17 CNTA M $35K
2025-11-17 CNTA $166K
2025-11-17 CNTA M $0
2025-10-15 CNTA M $35K

Other Insiders at CNTA (90d)

Insider Bought Sold Last
Weinhoff Gregory M
Chief Business Officer
$2.6M 2026-03-26
Crowley John J
Chief Financial Officer
2026-02-02
Kanes Stephen
Chief Medical Officer
2026-02-02
Anderson Karen M.
Chief People Officer
$6.5M 2026-03-26
HUSSAIN IQBAL J
Chief Legal Officer
$1.0M 2026-02-02
Bush Tia L
Chief Technology & Quality Ofc
2026-02-02
Deferiere Raphael
Chief Accounting Officer
2026-02-02
Accardi Mario Alberto
Chief Executive Officer
2026-02-02